ADVENZYMES

Advanced Enzyme Technologies Share Price

 

 

Invest in Advanced Enzyme Technologies with 2.65X leverage

Invest with MTF
Advanced Enzyme Technologies live price: ₹265.9. It opened at ₹268 vs previous close ₹275; intraday high/low: ₹273/₹261. The 50 & 200 DMA stand at ₹289.17/₹307.71.

Advanced Enzyme Technologies Performance

  • Today's Low
  • ₹261
  • Today's High
  • ₹273
  • 52 Week Low
  • ₹259
  • 52 Week High
  • ₹366
  • Open Price₹268
  • Previous Close₹275
  • Volume200,930
  • 50 DMA₹289.17
  • 100 DMA₹296.71
  • 200 DMA₹307.71

Investment Returns

  • Over 1 Month -11.46%
  • Over 3 Month -10.11%
  • Over 6 Month -16.91%
  • Over 1 Year -4.04%

Smart Investing Starts Here Start SIP with Advanced Enzyme Technologies for Steady Growth!

Invest Now

Advanced Enzyme Technologies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 19.5
  • PEG Ratio
  • 1.3
  • Market Cap Cr
  • 2,976
  • P/B Ratio
  • 1.9
  • Average True Range
  • 10.73
  • EPS
  • 12.86
  • Dividend Yield
  • 2
  • MACD Signal
  • -5.31
  • RSI
  • 36.74
  • MFI
  • 40.63

Advanced Enzyme Technologies Financials

Advanced Enzyme Technologies Technicals

EMA & SMA

Current Price
₹265.90
-8.6 (-3.13%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹281.19
  • 50 Day
  • ₹289.17
  • 100 Day
  • ₹296.71
  • 200 Day
  • ₹307.71

Resistance and Support

266.6 Pivot Speed
  • R3 284.40
  • R2 278.70
  • R1 272.30
  • S1 260.20
  • S2 254.50
  • S3 248.10

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Advanced Enzyme Technologies Ltd. is a leading global manufacturer of enzymes and probiotics, catering to various industries including pharmaceuticals, food, animal nutrition, and textiles. It offers sustainable, high-performance solutions that enhance efficiency and reduce environmental impact.

Advanced Enzyme Techs. has an operating revenue of Rs. 709.57 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 29% is great, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 25% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 59 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 78 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Advanced Enzyme Technologies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-31 Quarterly Results
2025-11-12 Quarterly Results
2025-08-02 Quarterly Results
2025-05-13 Audited Results, Interim & Final Dividend
2025-02-08 Quarterly Results
Date Purpose Remarks
2025-07-23 FINAL Rs.1.20 per share(60%)Final Dividend
2025-05-17 INTERIM Rs.4.00 per share(200%)Interim Dividend
2024-07-18 FINAL Rs.1.10 per share(55%)Final Dividend
2024-05-18 INTERIM Rs.4.00 per share(200%)Interim Dividend
2023-08-05 FINAL Rs.1.00 per share(50%)Final Dividend
View Advanced Enzyme Technologies Dividend History Arrow

Advanced Enzyme Technologies F&O

Advanced Enzyme Technologies Shareholding Pattern

43.04%
2.16%
13.78%
17.45%
23.57%

Advanced Enzyme Technologies FAQs

Advanced Enzyme Technologies share price is ₹265 As on 29 March, 2026 | 03:55

The Market Cap of Advanced Enzyme Technologies is ₹2976.1 Cr As on 29 March, 2026 | 03:55

The P/E ratio of Advanced Enzyme Technologies is 19.5 As on 29 March, 2026 | 03:55

The PB ratio of Advanced Enzyme Technologies is 1.9 As on 29 March, 2026 | 03:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23